Elutia (ELUT) Return on Sales (2019 - 2026)

Elutia (ELUT) posted Return on Sales of 0.0% for Q1 2026, down 99.42% sequentially from 0.24% in Q4 2025, and up 1.0% YoY from 0.0% in Q1 2025.

Elutia (ELUT) Return on Sales (2019 - 2026) Analysis & Trends

Elutia has reported Return on Sales for 8 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Sales rose 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 4.0% YoY) and the FY2025 annual result came in at 0.06%, up 6.0% from the prior year.
Return on Sales retreated to 0.0% in Q1 2026 per ELUT's latest filing, from 0.24% in the prior quarter.
Over five years, Return on Sales peaked at 0.24% in Q4 2025 and troughed at 0.03% in Q1 2024.
A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
The sharpest annual moves came in 2024 and 2025: Return on Sales declined 3 bps in 2024, then rose 24 bps in 2025.
Over 5 years, Return on Sales stood at 0.0% in 2022, then soared by 1052 bps to 0.01% in 2023, then plunged by 167 bps to 0.01% in 2024, then soared by 3592 bps to 0.24% in 2025, then slumped by 99 bps to 0.0% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.24%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	202.48 Bn	196.88 Bn	7.27 Bn	0.00%
2	Stryker	127.02 Bn	123.54 Bn	4.50 Bn	0.00%
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	0.00%
4	Boston Scientific	74.52 Bn	73.98 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.81 Bn	47.55 Bn	1.35 Bn	0.00%
6	Dexcom	34.91 Bn	32.96 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.82 Bn	31.71 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.29 Bn	22.97 Bn	4.55 Bn	0.00%
9	Steris	23.23 Bn	22.75 Bn	684.20 Mn	0.00%
10	Elutia	40.70 Mn	20.81 Mn	1.45 Mn	-0.03%

Download Data